142 related articles for article (PubMed ID: 15027876)
21. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
[TBL] [Abstract][Full Text] [Related]
22. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE
Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406
[TBL] [Abstract][Full Text] [Related]
23. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of new 4-[2-(4-methyl(amino)sulfonylphenyl)-5-trifluoromethyl-2H-pyrazol-3-yl]-1,2,3,6-tetrahydropyridines: a search for novel nitric oxide donor anti-inflammatory agents.
Chowdhury MA; Abdellatif KR; Dong Y; Knaus EE
Bioorg Med Chem; 2008 Oct; 16(19):8882-8. PubMed ID: 18789699
[TBL] [Abstract][Full Text] [Related]
25. Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Chen QH; Knaus EE
Bioorg Med Chem; 2008 Mar; 16(6):3302-8. PubMed ID: 18096394
[TBL] [Abstract][Full Text] [Related]
26. Metallo-nucleosides: synthesis and biological evaluation of hexacarbonyl dicobalt 5-alkynyl-2'-deoxyuridines.
Sergeant CD; Ott I; Sniady A; Meneni S; Gust R; Rheingold AL; Dembinski R
Org Biomol Chem; 2008 Jan; 6(1):73-80. PubMed ID: 18075651
[TBL] [Abstract][Full Text] [Related]
27. Design and development of water-soluble curcumin conjugates as potential anticancer agents.
Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA
J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
29. Hantzsch 1,4-dihydropyridines containing a diazen-1-ium-1,2-diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release.
Nguyen JT; Velázquez CA; Knaus EE
Bioorg Med Chem; 2005 Mar; 13(5):1725-38. PubMed ID: 15698790
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 5-[alkoxy-(4-nitro-phenyl)-methyl]-uridines and study of their cytotoxic activity.
Brulíková L; Dzubák P; Hajdúch M; Lachnitová L; Kollareddy M; Kolár M; Bogdanová K; Hlavác J
Eur J Med Chem; 2010 Sep; 45(9):3588-94. PubMed ID: 20605656
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failure.
Velázquez C; Knaus EE
Bioorg Med Chem; 2004 Jul; 12(14):3831-40. PubMed ID: 15210150
[TBL] [Abstract][Full Text] [Related]
34. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Andersen NK; Jepsen JS; Hansen FG; Haselmann KF; Nielsen C; Wengel J
Bioorg Med Chem; 2005 Apr; 13(7):2597-621. PubMed ID: 15755661
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 3-aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor properties.
Bezerra NM; De Oliveira SP; Srivastava RM; Da Silva JR
Farmaco; 2005; 60(11-12):955-60. PubMed ID: 16242685
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiproliferative activity of O-silylated nucleoside triazene N-oxide derivatives.
Tronchet JM; Grivet C; Grand E; Seman M; Dilda P
Carbohydr Lett; 2000; 4(1):5-12. PubMed ID: 11469337
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of a C6 nucleoside analogue for the in vivo imaging of the gene expression of herpes simplex virus type-1 thymidine kinase (HSV1 TK).
Johayem A; Raić-Malić S; Lazzati K; Schubiger PA; Scapozza L; Ametamey SM
Chem Biodivers; 2006 Mar; 3(3):274-83. PubMed ID: 17193264
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of nitric oxide-donating thalidomide analogues as anticancer agents.
Wang T; Zhang YH; Kong XW; Lai YS; Ji H; Chen YP; Peng SX
Chem Biodivers; 2009 Apr; 6(4):466-74. PubMed ID: 19353543
[TBL] [Abstract][Full Text] [Related]
40. A diazen-1-ium-1,2-diolated nitric oxide donor ester prodrug of 3-(4-hydroxymethylphenyl)-4-(4-methanesulfonylphenyl)-5H-furan-2-one: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Huang Z; Chowdhury MA; Kaufman S; Knaus EE
Bioorg Med Chem Lett; 2011 Jul; 21(13):3951-6. PubMed ID: 21641217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
